retatrutide investigational drug weight loss peptide for and fat burning Triple hormone receptor agonist retatrutide

doi:10.1016/j.physbeh.2011.01.012 64

A patient starting a GLP-1RAespecially if they have diabetes or age-related macular degeneration should have an in-person, comprehensive, dilated eye examination either within the 12 months prior to starting therapy or a baseline examination within one month of initiating therapy, according to the report

Using them together would double-dose you with semaglutide, increasing the risk of side effects without providing additional benefits

The correct dosage will be case specific, so work with a functional medicine doctor to figure out which types and what dosages are best for you (what works for someone else may not be right for you)